CureVac COVID-19 vaccine

The CureVac COVID-19 vaccine was a COVID-19 vaccine candidate created by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). 

The vaccine showed bad results in its Phase III trials with only 47% effective.  The vaccine was never sold.

References

Category:COVID-19 pandemic